Large-scale testing (Phase 3)Study completedNCT04843761
What this trial is testing
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 473